Regulus Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Regulus Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Regulus Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $140M, a 6.11% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $140M +$8.08M +6.11% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $132M +$7.33M +5.87% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $125M +$6.66M +5.64% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $118M +$2.61M +2.25% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $116M +$604K +0.53% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $115M +$12.3M +12% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $103M -$990K -0.96% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $104M +$32M +44.7% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $71.6M +$23.2M +47.9% Dec 31, 2015 10-K 2017-03-03
Q4 2014 $48.4M +$20.1M +71.1% Dec 31, 2014 10-K 2016-02-23
Q4 2013 $28.3M +$9.03M +46.8% Dec 31, 2013 10-K 2015-02-19
Q4 2012 $19.3M +$5.39M +38.8% Dec 31, 2012 10-K 2014-02-28
Q4 2011 $13.9M Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.